At Great Plains Biotechnology, we are constantly looking for ways to improve our client's experience. Stay up-to-date on our latest company news right here. We started serving new clients in 2013. Please contact us to let us know how we can help you!
In May 2016, Univac, an international biotech company focused on developing innovative vaccines based on activation of NK cells, announced the appointment of Stefano Malvolti, MSc, MPH to the position of Chief Executive Officer and Tyler Martin, MD as Independent Director and Chairman of its Board of Directors.
Moving forward with Heplisav / Dr J Tyler Martin - Dynavax - World Vaccine Congress